Welcome to the Team, Andy
In a breakthrough move, Scantox Group, a front-runner in nonclinical services across Europe, has welcomed Andy Brown aboard as Group Chief Commercial Officer. Tasked with escalating sales in toxicology, discovery, and lab services, Brown will be a key player in nurturing fruitful relationships with both existing and potential clients.
A Collaborative Endeavour
Joining forces with the executive management team and Impilo, Andy’s new role encompasses a major part in Scantox Group’s overall strategy. His main objective? Driving both organic and inorganic growth within the corporation. “We will continue to focus our efforts on doing the things that customers value most,” Brown pledged. Emphasizing their growth strategy, he elaborated on the expansion of their preclinical services to meet customers’ escalating needs.
Stalwart Leadership
Andy Brown’s commercial leadership is result-oriented and backed by a proven record of success in both small and large contract research organizations (CRO). His experience commercializing toxicology, discovery, and bioanalysis services makes him an ideal fit for Scantox Group.
Depth of Experience
Previously, Brown had a successful tenure at AltaSciences (formerly Sinclair Research) where he initially served as the VP of Commercial Operations from 2018-2021. During his time as VP, the company’s sales and revenue more than tripled. AltaSciences acknowledged his contribution by appointing him as the General Manager for their Preclinical Site in Columbia, Missouri.
Proven Track Record
In his role as General Manager, Brown had overall responsibility for operations, research, quality, facilities, EHS, accounting, and HR. He was instrumental in spearheading several process improvement initiatives that significantly enhanced data quality and on-time reporting. He also played a crucial part in the expansion and infrastructure improvement projects of the facility.
A Valuable Addition
“Andy’s preclinical market knowledge and experience in the CRO industry bring significant value to Scantox Group and all its customers,” Jeanet Løgsted, Chief Executive Officer of Scantox Group, praised. She pointed out his leadership skills, passion for innovation, and customer-centric approach as vital assets that will further fuel Scantox Group’s growth.
FAQs
1. Who is Andy Brown?
Andy Brown is a result-oriented commercial leader with a track record of successfully growing contract research organizations. He has a wealth of experience commercializing toxicology, discovery, and bioanalysis services.
2. What is Andy Brown’s role in Scantox Group?
As the Group Chief Commercial Officer, Andy Brown is tasked with growing sales within toxicology, discovery, and lab services. He is also responsible for fostering positive relationships with current and prospective clients.
3. What experience does Andy Brown bring to Scantox Group?
Andy Brown brings a wealth of experience from his time at AltaSciences, where he served as the VP of Commercial Operations and later as the General Manager for the company’s Preclinical Site. His tenure saw a significant increase in company sales and revenue.
4. What was the impact of Andy Brown’s leadership at AltaSciences?
During his tenure as VP of Commercial Operations at AltaSciences, the company’s sales and revenue more than tripled. As the General Manager, he was responsible for operations, research, quality, facilities, EHS, accounting, and HR, and led several process improvement initiatives.
5. How will Andy Brown contribute to Scantox Group’s growth?
Andy Brown is expected to drive the organic and inorganic growth of Scantox Group as part of its overall strategy. His leadership skills, passion for innovation, and customer-centric approach are expected to be invaluable for the company’s future growth.
Key Stats Table
| Stats | Details |
| Company | Scantox Group |
| New Appointment | Andy Brown |
| Position | Group Chief Commercial Officer |
| Former Company | AltaSciences (formerly Sinclair Research) |
| Former Position at AltaSciences | VP of Commercial Operations (2018-2021), General Manager |
| Impact at AltaSciences | Tripled sales and revenue |
Bernie Grady is a technology and business journalist who writes about trending topics in the world of technology, entertainment, and business. She has a keen eye for spotting new trends and loves to share her insights with her readers. Bernie has been writing professionally for over 10 years and has experience covering a wide range of topics. When she’s not writing, she enjoys spending time with her family and friends.